Five-Year Outcomes after Off-Pump or On-Pump Coronary-Artery Bypass Grafting. 2016

André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
From the Population Health Research Institute, Hamilton Health Sciences, McMaster University, Hamilton, ON (A.L., P.J.D., R.P.W., Y.O., P.G., S.P., S.Y.), Centre Hospitalier de l'Université de Montréal, Montreal (N.N.), and the University of Calgary, Calgary, AB (R.J.N.) - all in Canada; the Center for Chronic Disease Control, Gurgaon (D.P.), SAL Hospital, Ahmedabad (A.R.J.), G. Kuppuswamy Naidu Memorial Hospital, Coimbatore (C.P.), and All India Institute of Medical Sciences, New Delhi (B.A.) - all in India; the University of Oxford, Oxford, United Kingdom (D.P.T.); Fu Wai Cardiovascular Hospital, Xicheng District, Beijing (S.H.), and Wuhan Asia Heart Hospital, Wuhan (L.T.) - both in China; Third Faculty of Medicine Charles University, University Hospital Kralovske Vinohrady, Prague, Czech Republic (Z.S.); Instituto Dante Pazzanese de Cardiologia, São Paulo (L.S.P., A.A.); Ankara University School of Medicine, Ankara, Turkey (A.R.A.); Hospital Regional de Temuco and Universidad de la Frontera, Temuco, Chile (F.L.Z., J.-C.B.); Fundación Médica de Río Negro y Neuquén, Rio Negro, Argentina (P.A.O.); and North Estonia Medical Center, Tallinn, Estonia (T.-A.S.).

We previously reported that there was no significant difference at 30 days or at 1 year in the rate of the composite outcome of death, stroke, myocardial infarction, or renal failure between patients who underwent coronary-artery bypass grafting (CABG) performed with a beating-heart technique (off-pump) and those who underwent CABG performed with cardiopulmonary bypass (on-pump). We now report the results at 5 years (the end of the trial). A total of 4752 patients (from 19 countries) who had coronary artery disease were randomly assigned to undergo off-pump or on-pump CABG. For this report, we analyzed a composite outcome of death, stroke, myocardial infarction, renal failure, or repeat coronary revascularization (either CABG or percutaneous coronary intervention). The mean follow-up period was 4.8 years. There were no significant differences between the off-pump group and the on-pump group in the rate of the composite outcome (23.1% and 23.6%, respectively; hazard ratio with off-pump CABG, 0.98; 95% confidence interval [CI], 0.87 to 1.10; P=0.72) or in the rates of the components of the outcome, including repeat coronary revascularization, which was performed in 2.8% of the patients in the off-pump group and in 2.3% of the patients in the on-pump group (hazard ratio, 1.21; 95% CI, 0.85 to 1.73; P=0.29). The secondary outcome for the overall period of the trial - the mean cost in U.S. dollars per patient - also did not differ significantly between the off-pump group and the on-pump group ($15,107 and $14,992, respectively; between-group difference, $115; 95% CI, -$697 to $927). There were no significant between-group differences in quality-of-life measures. In our trial, the rate of the composite outcome of death, stroke, myocardial infarction, renal failure, or repeat revascularization at 5 years of follow-up was similar among patients who underwent off-pump CABG and those who underwent on-pump CABG. (Funded by the Canadian Institutes of Health Research; CORONARY ClinicalTrials.gov number, NCT00463294 .).

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009203 Myocardial Infarction NECROSIS of the MYOCARDIUM caused by an obstruction of the blood supply to the heart (CORONARY CIRCULATION). Cardiovascular Stroke,Heart Attack,Myocardial Infarct,Cardiovascular Strokes,Heart Attacks,Infarct, Myocardial,Infarction, Myocardial,Infarctions, Myocardial,Infarcts, Myocardial,Myocardial Infarctions,Myocardial Infarcts,Stroke, Cardiovascular,Strokes, Cardiovascular
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D011788 Quality of Life A generic concept reflecting concern with the modification and enhancement of life attributes, e.g., physical, political, moral, social environment as well as health and disease. HRQOL,Health-Related Quality Of Life,Life Quality,Health Related Quality Of Life
D012086 Reoperation A repeat operation for the same condition in the same patient due to disease progression or recurrence, or as followup to failed previous surgery. Revision, Joint,Revision, Surgical,Surgery, Repeat,Surgical Revision,Repeat Surgery,Revision Surgery,Joint Revision,Revision Surgeries,Surgery, Revision
D003324 Coronary Artery Disease Pathological processes of CORONARY ARTERIES that may derive from a congenital abnormality, atherosclerotic, or non-atherosclerotic cause. Arteriosclerosis, Coronary,Atherosclerosis, Coronary,Coronary Arteriosclerosis,Coronary Atherosclerosis,Left Main Coronary Artery Disease,Left Main Coronary Disease,Left Main Disease,Arterioscleroses, Coronary,Artery Disease, Coronary,Artery Diseases, Coronary,Atheroscleroses, Coronary,Coronary Arterioscleroses,Coronary Artery Diseases,Coronary Atheroscleroses,Left Main Diseases
D005260 Female Females
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
March 2017, The New England journal of medicine,
André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
November 2017, The New England journal of medicine,
André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
November 2017, The New England journal of medicine,
André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
August 2017, The New England journal of medicine,
André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
November 2017, The New England journal of medicine,
André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
November 2017, The New England journal of medicine,
André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
April 2019, Circulation,
André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
July 2013, The New England journal of medicine,
André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
July 2013, The New England journal of medicine,
André Lamy, and P J Devereaux, and Dorairaj Prabhakaran, and David P Taggart, and Shengshou Hu, and Zbynek Straka, and Leopoldo S Piegas, and Alvaro Avezum, and Ahmet R Akar, and Fernando Lanas Zanetti, and Anil R Jain, and Nicolas Noiseux, and Chandrasekar Padmanabhan, and Juan-Carlos Bahamondes, and Richard J Novick, and Liang Tao, and Pablo A Olavegogeascoechea, and Balram Airan, and Toomas-Andres Sulling, and Richard P Whitlock, and Yongning Ou, and Peggy Gao, and Shirley Pettit, and Salim Yusuf, and
July 2013, The New England journal of medicine,
Copied contents to your clipboard!